FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Certificates

FDA
Registration Date 16 Nov 2016
Share

RESTASIS

(0)

Medicine Pharmaceuticals Product Number : 0023-9163-60

Anti-inflammatory Drug

Drug Information

Generic
Cyclosporin A
NDC Code
0023-9163-60
Drug Class
Ophthalmic anti-inflammatory agents
Therapeutic Class
anti-inflammatory
Dosage form
Solution
Route of Administration
OPHTHALMIC
Therapeutic Area
1.immunosuppressant

Indication

Restasis® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.

Benefit

RESTASIS® Ophthalmic Emulsion helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs